Growth momentum Cerapedics is a commercial-stage orthopedics company with FDA-approved i-FACTOR and PearlMatrix bone grafts, indicating strong market penetration and ongoing expansion potential in spine, orthopedics, trauma, and interventional procedures.

Headcount expansion Frequent announcements of significant headcount growth and office expansions in Colorado suggest increased sales capacity, field presence, and potential demand for additional sales, training, and field support resources.

FDA approved portfolio Two FDA-approved peptide-enhanced bone graft products provide a solid entry point for penetrating hospitals and surgical centers, with opportunities to upsell related products, training, and procedure adoption programs.

Clinical momentum Recent long-term follow-up data from pivotal IDE studies for i-FACTOR reinforce clinical efficacy and can be leveraged to drive clinician adoption, payer conversations, and cross-sell within spine and orthopedics workflows.

Strategic partnerships Past collaborations on next-generation peptide-enhanced grafts indicate openness to partnerships and co-development, presenting a pathway for distribution deals, regional expansions, or technology licensing to accelerate market reach.